Latest News-Wuxi Biologics Mediaroom_Page

WuXi Biologics Announces GMP Release of 48,000L Commercial Drug Substance Manufacturing Facility in Hebei, China

- The 11th drug substance facility is released for cGMP operation in the WuXi Biologics' global ma...

2022-10-26 12:30 2621

WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities

* WuXi Biologics adds further capacity and capability for drug product fill & finish, providing g...

2022-10-24 08:30 2456

WuXi Biologics Receives "Best CDMO Award of the Year"

SHANGHAI, Oct. 13, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Co...

2022-10-14 09:00 2222

WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody

SHANGHAI, Oct. 11, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Con...

2022-10-12 09:00 2522

WuXi Biologics Co., Ltd. Removed from Unverified List

WUXI, China, Oct. 10, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio", 2269.HK), a leading global C...

2022-10-10 07:55 4450

WuXi Biologics Topped Off the Steel on its Commercial Biomanufacturing Facility in Worcester, Massachusetts

WORCESTER, Mass., Sept. 29, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global Co...

2022-09-29 10:41 2019

WuXi Biologics' Drug Substance and Drug Product Facilities Again Approved by U.S. FDA and EMA

WUXI, China, Sept. 20, 2022 /PRNewswire/ --WuXi Biologics ("WuXi Bio") (2269.HK), a leading global ...

2022-09-20 10:48 2528

WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility in Cranbury, New Jersey

CRANBURY, N.J., Aug. 31, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global leadi...

2022-08-31 20:00 2762

WuXi Biologics Reports Strong 2022 Interim Results

Revenue Increased by 63.5% Y-o-Y to RMB7,206.4 Million Gross Profit Increased by 48.6% Y-o-Y to RMB...

2022-08-17 21:32 4028

WuXi Biologics Again Selected as Constituent of FTSE4Good Index Series

SHANGHAI, Aug. 16, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global leading Con...

2022-08-17 10:12 3022

WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore

* This investment will establish a cutting-edge, fully integrated CRDMO center inSingapore, inclu...

2022-07-19 18:03 3119

WuXi Vaccines Received First GMP Certificate of QC Potency Lab from Ireland Health Products Regulatory Authority

- The first GMP certificate that WuXi Vaccines has received from the regulatory agency - A critica...

2022-07-12 16:00 2077

WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates

SHANGHAI and SEOUL, South Korea, July 7, 2022 /PRNewswire/ -- WuXi XDC, a global leading CRDMO (Con...

2022-07-08 09:27 4740

WuXi Biologics Extends Capabilities to Include Development and cGMP Manufacturing for Microbial-Derived Products

* WuXi Biologics expands its extensive integrated CRDMO services by offering development and cGMP...

2022-07-05 08:30 2868

WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes

* WuXi Biologics offers global partners high-efficiency and high-quality manufacturing services f...

2022-06-06 08:30 4305

WuXi Biologics' 2021 ESG Report Reveals Company's Strong Commitment to Overall Sustainability

- WuXi Biologics has aligned its ESG strategy with the United Nations Sustainable Development Goa...

2022-04-28 08:30 2339

WuXi Biologics Receives Bioprocessing Excellence Award from IMAPAC

SINGAPORE, April 14, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global Contract ...

2022-04-15 09:03 2473

WuXi Biologics Achieved Record Growth and Profitability in 2021

Banner Year for Commercial Manufacturing Revenue Increased by 83.3% Y-o-Y to RMB10,290.1 Million G...

2022-03-23 00:38 3296

WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics

SHANGHAI, March 14, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO serv...

2022-03-14 20:30 2665

WuXi Biologics Wins CMO Leadership Awards in All Six Core Categories for Fifth Consecutive Year

SHANGHAI, March 1, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO servi...

2022-03-02 10:07 2309